Table 3.
The extent to which to safety and clinical governance systems are in place
| n = number of respondents who answered the question |
Yes |
No |
||
|---|---|---|---|---|
| n | % | n | % | |
| 1. I have provided my employer with a specimen signature (n = 759) |
694 |
91.4 |
65 |
8.6 |
| 2. My employer provides me with each edition of the BNF/the NPF for Community Practitioners (n = 714) |
655 |
91.2 |
59 |
8.6 |
| 3. My employer ensures that I receive all relevant clinical information e.g. Patient Safety Notices, Drug Alerts and Hazard Warnings? (n = 758) |
678 |
89.5 |
80 |
10.5 |
| 4. My employer has an up-to-date NMP policy (n = 740) |
655 |
88.5 |
85 |
11.5 |
| 5. My scope of practice has been agreed with my employer (n = 754) |
642 |
85.1 |
112 |
14.9 |
| 6. I know how to contact my NMP lead (n = 754) |
629 |
83.4 |
125 |
16.6 |
| 7. I have access to CPD to support me in prescribing role (via employer/trust/independently) (n = 755) |
561 |
74.3 |
194 |
25.7 |
| 8. I am involved with regular clinical audit and review of my clinical services (n = 750) |
480 |
64.0 |
270 |
26.0 |
| 9. My employer has involved me in the development of local formularies and guidelines (n = 755) |
358 |
47.7 |
397 |
52.6 |
| 10. My employer provides me with regular data to monitor my prescribing practice (n = 751) |
328 |
43.7 |
423 |
16.3 |
| 11. I am able to access my own prescribing data (via PACT or otherwise) (n = 746) | 281 | 37.3 | 465 | 62.3 |
(NMP = non medical prescribing, BNF = British National Formulary, NPF = Nurse Prescribers Formulary, PACT = Prescription analysis and cost trend, CPD = continuing professional development).